Studies have shown the benefits of phosphate reduction in dogs and cats suffering from kidney failure. It’s now widely accepted that there’s a direct link between the length and quality of life of a dog or cat with kidney insufficiency and the phosphate levels they get through their food. As such, Ipakitine acts to reduce phosphorus blood concentration and uremia, resulting in an increase in life expectancy. Ipakitine key benefits: increases food intake, which I presume is because of the B vitamins. It also claims that by using this product, you can If animal’s condition worsens or does not improve, stop product administration and consult your veterinarian. Plantinga EA, Everts H, Kastelein AMC, Beynen AC. Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets. Vet Rec. 2005; 157:185–187. [ PubMed] [ Google Scholar] because the binder may reduce the bioavailability of the ACE inhibitors. Drugs has more information about this.

Sometimes, our loving pets are just like us, and they develop unfortunate health conditions with age. If your dog or cat suffers from chronic renal failure, you need to give them Ipakitine to help control renal function.Elliott J, Barber PJ. Feline chronic renal failure: clinical findings in 80 cases diagnosed between 1992 and 1995. J Small Anim Pract. 1998; 39:78–85. doi: 10.1111/j.1748-5827.1998.tb03598.x. [ PubMed] [ CrossRef] [ Google Scholar] Renal health: Ipakitine contains Chitosan that captures uremic toxins in the intestine, preventing their passage into the blood, and Calcium carbonate that limits phosphorus uptake by capturing phosphates. This double-action mechanism of Ipakitine prevents renal damage from progressing. There are no reported side effects. In case of accidental overdosing and before using your veterinarian is the best source of advice. Always discuss in detail if your pet is on other medications or renal supplements or calcium/phosphorus regulators like calcitrol. Any item not in its original condition, is damaged or missing parts for reasons not due to our error The difference between products containing an IPB appears to be even more pronounced when refusal to consume is assessed with around half of all cats refusing to consume the two previously existing products.

Zhang G, el Nahas AM. The effect of rhubarb extract on experimental renal fibrosis. Nephrol Dial Transplant. 1996; 11:186–190. doi: 10.1093/oxfordjournals.ndt.a027039. [ PubMed] [ CrossRef] [ Google Scholar] Here is a summary of the pros and cons of each binder type. Ultimately, if your cat needs a phosphorus management of hyperphosphatemia in patients in hemodialysis (2011) Vasantha J, Soundararajan P, Vanitharani N, Kannan G, Calcium-containing products such as Ipakitine may cause increased calcium levels ( hypercalcaemia). The risk is lower with calcium carbonate-based binders (such as Ipakitine) than with other calcium-based binders, and the manufacturer claims it is less likely to happen with the form of calcium carbonate which they use, but if your cat is taking Ipakitine, it would probably be wise to monitor his/her calcium levels.​ of niacinamide for reduction of phosphorus in hemodialysis patients (2008) Cheng SC, Young DO, Huang Y, Delmez JA & Coyne DW

carbonate which they use, but if your cat is taking Ipakitine, it would probably be wise to monitor continued use of aluminium binders...The relative contribution of aluminium binders to aluminium toxicity would Ipakitine is a food supplement used to manage both dogs and cats with chronic kidney failure by reducing the absorption of phosphates. Ipakitine contains Chitosan and Calcium Carbonate, which act as phosphate binding agents and lower the absorption of phosphates restricted food. There is also a reduction in the absorption of some waste products that can affect normal kidney function. Epakitin ® is a chitosan-based phosphate binder that supports normal function and health of the kidneys in cats and dogs. Directions For Use hyperphosphatemia in patients with end stage renal disease (2016) Zahed NS, Zamanifar N & Nikbakht H Indian Journal of